Showing 161 - 170 of 27,957
Almost three decades ago, Congress created by statute the modern patent reexamination system. By providing an … attempt invalidation of patents in court. Most analyzes of the system focus on modifying the existing provisions of the Patent … patent. In reality, the behavior of firms runs counter to this assumption, with parties avoiding reading of patents as a …
Persistent link: https://www.econbiz.de/10014211911
lower prices. Innovation prizes and other non-patent rewards are becoming more prevalent in government's innovation policy …, and are also widely implemented by private philanthropists. In this paper we describe situations in which a patent buyout … policy still involves some form of patent buyout. The buyout uses two key pieces of information: market outcomes observed …
Persistent link: https://www.econbiz.de/10014154426
Using a simple downstream duopoly model with vertical relations and downstream R&D, we investigate the effect of non-assertion of patents (NAP) provisions. A monopoly upstream firm decides whether to employ NAP provisions. If it does so, it freely incorporates the R&D outcomes into its inputs....
Persistent link: https://www.econbiz.de/10013126828
patenting firms in the population of registered companies. Also, there is evidence suggesting that firms may not patent all …
Persistent link: https://www.econbiz.de/10014130631
In high technology areas such as biotechnology and computer software, the U.S. Patent and Trademark Office (PTO) is … to grant patent rights commensurate with innovation and to avoid the detrimental consequences of an overbroad patent … well-informed patentees to reveal information regarding the relevant prior art to the PTO during patent prosecution. This …
Persistent link: https://www.econbiz.de/10014133978
subsidizing the costs of patent applications has no impact on the outcome …
Persistent link: https://www.econbiz.de/10014068691
This working paper critically examines the pharmaceutical industry and the incentive argument in patent law. It begins … by framing an overview of the industry and patent law, focusing on U.S. and U.K. law, and multilateral agreements, and … efforts by international organizations, such as the World Trade Organization (WTO). Next, the paper considers patent incentive …
Persistent link: https://www.econbiz.de/10014077712
This paper reexamines how a shift in demand for pharmaceutical treatments affects innovation as measured by new patent … filings. Using U.S. Patent & Trademark Office data on pharmaceutical patenting between 1998-2019 for 40 drug therapeutic …
Persistent link: https://www.econbiz.de/10014081937
Persistent link: https://www.econbiz.de/10013422681
a plausibly exogenous change to patent duration. Second, the nature of the law change meant that the patent duration … change was heterogeneous across patent classes. Using both patent counts and citation-weighted counts, I am able to take … advantage of the TRIPS-induced law change to empirically estimate the impact of patent duration on innovation. I find evidence …
Persistent link: https://www.econbiz.de/10014046329